Patient & Survivor Care
Conference Coverage
Repeat MCED Testing May ID Early-Stage and Unscreened Cancers
Eight of 26 patients with cancer signals detected through MCED had cancer.
Conference Coverage
ImPrint Identifies Patients With Breast Cancer Likely to Respond to Neoadjuvant Immunotherapy
Experts discuss the first randomized clinical study to assess the efficacy of immunotherapy in patients with HR+/HER2- breast cancer.
From the Journals
Less Than 50% of Accelerated Approvals Show Clinical Benefit
Researchers review 46 cancer drugs granted accelerated approvals between 2013 and 2017.
Conference Coverage
Combo Therapy Prolongs Survival in Gastric Cancer Patients, Regardless of PD-L1 Expression
Researchers evaluate the efficacy and safety of first-line cadonilimab plus standard chemotherapy in patients with advanced or metastatic gastric...
News from the FDA/CDC
FDA Expands Enhertu Indication to HER2-Positive Solid Tumors
The agent had already been approved for several cancer types.
Feature
New Trials in Prostate Cancer: Could Your Patient Benefit?
Two new trials for patients with metastatic castration-resistant prostate cancer that involve remaining on therapy until disease progression...
Feature
Do Tumor-infiltrating Lymphocytes Predict Better Breast Cancer Outcomes?
A new study evaluates whether TILs can identify a subset of patients with triple-negative breast cancer with a very low risk of cancer recurrence...
From the Journals
Virtual Reality Brings Relief to Hospitalized Patients With Cancer
Patients were randomized to receive either 10 minutes of immersive VR distraction therapy or 10 minutes of two-dimensional guided imagery...
Feature
Prostate Cancer Tsunami Coming, Experts Caution
Expert suggests approaches for enabling earlier diagnosis of prostate cancer in men in low- to middle-income countries.
Feature
Should Opioids Be Used for Chronic Cancer Pain?
Prescribing strategies are partly driven by peer pressure, new research suggests.
Conference Coverage
Certain Pesticides Linked With Risk for Pancreatic Cancer
Researcher divided the entire French territory into 5529 spatial units and determined the number of pancreatic cancer cases per spatial unit per...